Transgender health: Hormonal management at 50 years and beyond

Valerie Libby; Mabel Lee; James H Liu

doi:10.1016/j.maturitas.2019.04.220

Transgender health: Hormonal management at 50 years and beyond

Maturitas. 2019 Aug:126:34-37. doi: 10.1016/j.maturitas.2019.04.220. Epub 2019 May 1.

Authors

Valerie Libby¹, Mabel Lee², James H Liu³

Affiliations

¹ University Hospitals MacDonald Women's Hospital, Department of Obstetrics and Gynecology, Case Western Reserve University School of Medicine, 11100 Euclid Avenue, Cleveland, OH 44106, United States. Electronic address: valerie.libby@UHhospitals.org.
² University Hospitals MacDonald Women's Hospital, Department of Obstetrics and Gynecology, Case Western Reserve University School of Medicine, 11100 Euclid Avenue, Cleveland, OH 44106, United States. Electronic address: mabel.lee@UHhospitals.org.
³ University Hospitals MacDonald Women's Hospital, Department of Obstetrics and Gynecology, Case Western Reserve University School of Medicine, 11100 Euclid Avenue, Cleveland, OH 44106, United States. Electronic address: James.Liu@UHhospitals.org.

PMID: 31239115
DOI: 10.1016/j.maturitas.2019.04.220

Abstract

This review discusses established transgender individuals on hormones who have reached their desired post-pubertal phenotype. Current guidelines have not clearly integrated specific considerations for the older population. This review focuses on changes in physiology with age, recommended maintenance therapy and safety evaluation to mitigate the risks of hormone therapy with a focus on the older population.

Keywords: Hormone regimen; Hormone safety; Transgender.

Publication types

Review

MeSH terms

Androgen Antagonists / therapeutic use*
Estrogens / therapeutic use*
Humans
Sex Reassignment Procedures
Testosterone / therapeutic use*
Transgender Persons*

Substances

Androgen Antagonists
Estrogens
Testosterone